Cavitary Upper-Lobe Disease with Negative Sputum Smears
A 62-year-old retired teacher with type 2 diabetes diagnosed 3 years ago (HbA1c 9.1%) presents with 8 weeks of productive cough, drenching night sweats, 6 kg weight loss and one episode of hemoptysis. Chest radiograph shows a thick-walled cavity in the right upper lobe. Two sputum samples are smear-negative for acid-fast bacilli; an interferon-gamma release assay is positive. HIV testing is negative. He lives with his wife and two young grandchildren and volunteers twice weekly at a homeless shelter. Five days ago an urgent-care clinic prescribed levofloxacin for presumed community-acquired pneumonia, with little improvement. He is afebrile but looks wasted; oxygen saturation is 94% on room air. Liver and renal function are normal, and platelet count is 210,000/µL. He received BCG vaccination as a child and has no prior tuberculosis treatment.
1. What is the diagnostic interpretation of the negative smears and positive IGRA, and what specimen tests should be ordered next?
Read the worked answer
Negative acid-fast smears do not exclude pulmonary tuberculosis; smear sensitivity is especially limited in paucibacillary disease and can be reduced by poor specimen quality. The positive IGRA indicates infection with Mycobacterium tuberculosis complex but cannot distinguish latent infection from active disease. The combination of a thick-walled upper-lobe cavity, weight loss, night sweats and hemoptysis makes active TB the leading diagnosis, not a incidental finding.
The recent levofloxacin is important: fluoroquinolones can transiently suppress M. tuberculosis and reduce culture yield, and prior fluoroquinolone exposure also raises concern about drug resistance. Obtain at least two, preferably three, good-quality sputum specimens for Xpert MTB/RIF Ultra and mycobacterial culture with drug-susceptibility testing. If sputum is scarce or testing is negative with persistent suspicion, use sputum induction with infection-control precautions or bronchoscopy with BAL. Send fungal studies and consider CT to characterize the cavity and assess for malignancy or nontuberculous mycobacteria, especially in a diabetic patient. Do not use the positive IGRA alone to start or withhold treatment; the decision should be based on the overall probability and microbiological results.
2. How should he be managed and isolated while results are pending?
Read the worked answer
He should be placed in airborne isolation immediately: a negative-pressure room if available, a fit-tested N95 or equivalent respirator for staff, and a surgical mask on the patient during transport. Notify the public-health TB program early, restrict visitors, and advise him not to attend the homeless shelter until he is noninfectious. The grandchildren and shelter contacts need contact investigation.
Because the clinical probability is high, do not wait for culture before starting standard four-drug therapy after specimens are collected. Baseline liver and renal function, complete blood count, visual acuity and color vision should be documented before ethambutol and other agents. The prior levofloxacin should not be continued as monotherapy; if a fluoroquinolone is part of a later regimen, resistance must be considered. Review diabetes control because poor glycemic control worsens outcomes.
If Xpert detects M. tuberculosis with a rpoB mutation, arrange urgent referral to a multidrug-resistant TB service and do not use a standard regimen blindly. Isolation can be stepped down only according to local criteria, usually after clinical improvement and negative cultures. The key error to avoid is discharging him with a presumed pneumonia diagnosis while cavitary TB remains untreated and transmissible.